| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6.
|
Blood
|
1989
|
2.78
|
|
2
|
Interleukin-6 induced at mucosal surfaces by gram-negative bacterial infection.
|
Infect Immun
|
1989
|
2.13
|
|
3
|
Clones of killer and helper T cells: growth requirements, specificity and retention of function in long-term culture.
|
Immunol Rev
|
1980
|
1.90
|
|
4
|
Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis.
|
Ann Rheum Dis
|
2004
|
1.84
|
|
5
|
Endotoxin, tumor necrosis factor-alpha and interleukin 1 induce interleukin 6 production in vivo.
|
Clin Immunol Immunopathol
|
1989
|
1.76
|
|
6
|
Sensitive ELISA for interleukin-6. Detection of IL-6 in biological fluids: synovial fluids and sera.
|
J Immunol Methods
|
1991
|
1.60
|
|
7
|
Interleukin-6 does not stimulate bone resorption in neonatal mouse calvariae.
|
J Bone Miner Res
|
1991
|
1.57
|
|
8
|
Interleukin (IL)-4 production by human T cells: differential regulation of IL-4 vs. IL-2 production.
|
Eur J Immunol
|
1992
|
1.57
|
|
9
|
Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis.
|
Ann Rheum Dis
|
2005
|
1.57
|
|
10
|
Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study.
|
Ann Rheum Dis
|
2009
|
1.34
|
|
11
|
Patients non-responding to etanercept obtain lower etanercept concentrations compared with responding patients.
|
Ann Rheum Dis
|
2011
|
1.20
|
|
12
|
Potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation.
|
J Immunol
|
1998
|
1.12
|
|
13
|
Avidity of antibodies to dsDNA: comparison of IFT on Crithidia luciliae, Farr assay, and PEG assay.
|
J Immunol
|
1982
|
1.06
|
|
14
|
The use of polyethylene glycol precipitation to detect low-avidity anti-DNA antibodies in systemic lupus erythematosus.
|
J Immunol Methods
|
1980
|
1.05
|
|
15
|
Comparison of the effects of recombinant interleukin 6 and recombinant interleukin 1 on nonspecific resistance to infection.
|
Eur J Immunol
|
1989
|
1.02
|
|
16
|
High levels of human anti-human antibodies to adalimumab in a patient not responding to adalimumab treatment.
|
Ann Rheum Dis
|
2006
|
1.01
|
|
17
|
Clinical response, pharmacokinetics, development of human anti-chimaeric antibodies, and synovial tissue response to rituximab treatment in patients with rheumatoid arthritis.
|
Ann Rheum Dis
|
2009
|
1.01
|
|
18
|
Complement-fixing antibodies to dsDNA detected by the immunofluorescence technique on Crithidia luciliae. A critical appraisal.
|
J Rheumatol
|
1985
|
0.99
|
|
19
|
Detection and characterization of DNA-anti-DNA complexes in a patient with systemic lupus erythematosus.
|
Clin Exp Immunol
|
1977
|
0.97
|
|
20
|
The proinflammatory cytokine response to coagulation and endotoxin in whole blood.
|
Blood
|
1996
|
0.94
|
|
21
|
Limiting dilution analysis of the suppressive effect mediated by alloantigen-primed cells.
|
Immunology
|
1980
|
0.92
|
|
22
|
Development of human Th1 and Th2 cytokine responses: the cytokine production profile of T cells is dictated by the primary in vitro stimulus.
|
Eur J Immunol
|
1993
|
0.92
|
|
23
|
Modulation of IL-6 production and IL-1 activity by keratinocyte-fibroblast interaction.
|
J Invest Dermatol
|
1993
|
0.90
|
|
24
|
Specificity in systemic lupus erythematosus of antibodies to double-stranded DNA measured with the polyethylene glycol precipitation assay.
|
Arthritis Rheum
|
1982
|
0.90
|
|
25
|
Cytokine-associated tissue injury and lethality in mice: a comparative study.
|
Clin Immunol Immunopathol
|
1991
|
0.90
|
|
26
|
Monokine production by human T cells; IL-1 alpha production restricted to memory T cells.
|
J Immunol
|
1991
|
0.88
|
|
27
|
Epstein-Barr virus-dependent lymphoproliferative disease: critical role of IL-6.
|
Eur J Immunol
|
2000
|
0.88
|
|
28
|
Effect of IL-4 and IL-6 on the proliferation and differentiation of B-chronic lymphocytic leukemia cells.
|
Leukemia
|
1993
|
0.88
|
|
29
|
Interleukin-6 production by tumor necrosis factor and lipopolysaccharide-stimulated rat renal cells.
|
Clin Immunol Immunopathol
|
1990
|
0.86
|
|
30
|
Measurement of low avidity anti-dsDNA by the Crithidia luciliae test and the PEG assay.
|
Clin Exp Immunol
|
1982
|
0.85
|
|
31
|
Characterisation of monoclonal antibodies to human IL-4: application in an IL-4 ELISA and differential inhibition of IL-4 bioactivity on B cells and T cells.
|
Eur Cytokine Netw
|
1994
|
0.85
|
|
32
|
Serum interleukin-6 levels and adverse reactions to diethylcarbamazine in lymphatic filariasis.
|
J Infect Dis
|
1992
|
0.81
|
|
33
|
Pharmacokinetics of rituximab in patients with CD20 positive B-cell malignancies.
|
Hum Antibodies
|
2010
|
0.81
|
|
34
|
Preferential decrease in IgG4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheumatoid arthritis.
|
Ann Rheum Dis
|
2008
|
0.81
|
|
35
|
Interleukin-4 inhibits both paracrine and autocrine tumor necrosis factor-alpha-induced proliferation of B chronic lymphocytic leukemia cells.
|
Blood
|
1992
|
0.81
|
|
36
|
The release of interleukin-12 in Escherichia coli-induced lethal and sublethal primate sepsis.
|
Ann N Y Acad Sci
|
1996
|
0.80
|
|
37
|
Apolipoprotein H, a new mediator in the inflammatory changes ensuring in jeopardised human myocardium.
|
J Clin Pathol
|
2000
|
0.80
|
|
38
|
Influence of pH on the detection of low- and high-avidity anti-dsDNA.
|
J Immunol Methods
|
1982
|
0.80
|
|
39
|
Functional analysis of synovial fluid and peripheral blood T cells from patients with rheumatoid arthritis.
|
Rheumatol Int
|
1995
|
0.80
|
|
40
|
On the interaction between agalactosyl IgG and Fc gamma receptors.
|
Eur J Immunol
|
1996
|
0.79
|
|
41
|
Soluble Fas levels in sera of bone marrow transplantation recipients are increased during acute graft-versus-host disease but not during infections.
|
Blood
|
1998
|
0.79
|
|
42
|
Human peripheral blood leukocyte engraftment into SCID mice: critical role of CD4(+) T cells.
|
Cell Immunol
|
2001
|
0.79
|
|
43
|
Differentiation of purified malignant B cells induced by PMA or by activated normal T cells.
|
Leukemia
|
1993
|
0.78
|
|
44
|
Sensitive measurement of thrombopoietin by a monoclonal antibody based sandwich enzyme-linked immunosorbent assay.
|
Thromb Haemost
|
1997
|
0.78
|
|
45
|
Studies on the monocyte dependence of T-cell proliferation induced by monoclonal antibodies directed against regions I and II of the CD2 antigen.
|
Immunology
|
1989
|
0.78
|
|
46
|
Cytokines and intracellular signals involved in the regulation of B-CLL proliferation.
|
Leuk Lymphoma
|
1993
|
0.77
|
|
47
|
Differential induction of interleukin-6 production by monocytes, endothelial cells and smooth muscle cells.
|
Prog Clin Biol Res
|
1991
|
0.77
|
|
48
|
Inhibition of interleukin-12 expression by alpha-thrombin in human peripheral blood mononuclear cells: a potential mechanism for modulating Th1/Th2 responses.
|
Br J Pharmacol
|
2003
|
0.75
|
|
49
|
Technical aspects of ANA determination.
|
Scand J Rheumatol Suppl
|
1985
|
0.75
|
|
50
|
Both naive and memory T cells can provide help for human IgE production, but with different cytokine requirements.
|
Eur Cytokine Netw
|
1992
|
0.75
|
|
51
|
TNF-alpha induces spreading of B-CLL via the CD11c/CD18 molecule.
|
Am J Hematol
|
1993
|
0.75
|